Form 4: Inspire Medical Systems Director Acquires Restricted Stock Units

Director Casey M. Tansey of Inspire Medical Systems, Inc. reports acquisition of restricted stock units and adjustments to beneficial ownership.

Summary

• On May 1, 2025, Casey M. Tansey, a director of Inspire Medical Systems, Inc., acquired 1,266 restricted stock units (RSUs).
• These RSUs will vest on the first anniversary of the grant date or upon a change of control, contingent upon continued employment.
• Following the transaction, Tansey directly owns 21,881 shares of common stock.
• Tansey also indirectly owns 500 shares through The Kimberly Tansey Irrevocable Trust and 500 shares through The Kylie Tansey Irrevocable Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of RSUs by a director is generally viewed positively, but it's a routine event.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future.

Future Outlook

The vesting of the RSUs is contingent upon continued employment and may also be triggered by a change of control event.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the ownership structure and management's stake in the company.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates

Keywords

Inspire Medical Systems, Director, Casey M. Tansey, Restricted Stock Units, RSUs, Beneficial Ownership, Form 4, Securities, Stock